Comparison of dapagliflozin and teneligliptin in nonalcoholic fatty liver disease patients without type 2 diabetes mellitus: a prospective randomized study

There are no reports regarding the efficacy of sodium-glucose cotransporter 2 inhibitor (SGLT2i) and dipeptidyl peptidase 4 inhibitor (DPP4i) administrations in nonalcoholic fatty liver disease (NAFLD) patients without type 2 diabetes mellitus. The purpose of this study was to evaluate the efficacy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Biochem Nutr
Hauptverfasser: Tobita, Hiroshi, Yazaki, Tomotaka, Kataoka, Masatoshi, Kotani, Satoshi, Oka, Akihiko, Mishiro, Tsuyoshi, Oshima, Naoki, Kawashima, Kousaku, Ishimura, Norihisa, Naora, Kohji, Sato, Shuichi, Ishihara, Shunji
Format: Artigo
Sprache:Inglês
Veröffentlicht: the Society for Free Radical Research Japan 2021
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8046003/
https://ncbi.nlm.nih.gov/pubmed/33879970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3164/jcbn.20-129
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge